Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Discover Hybrigenics Services new offer: ULTImate YChemH for your drug discovery & development projects

Product Image
Product Description

ULTImate YChemH (Yeast Chemical Hybrid) is an in-yeast compound profiling technique to identify protein partners of a given bioactive small molecule. Derived from Hybrigenics ULTImate Y2HTM (Yeast Two-Hybrid) service, it benefits from the same advantages with exhaustive screening of highly complex libraries, confidence score for partners ranking, minimal interaction domain determination and much more…

Applications

  • Identify hit targets and decipher mechanisms of action following a high-content screening
  • Study the off-target effect of an active compound
  • Support drug repositioning in new therapeutic areas
  • Evaluate safety of chemicals (toxico-proteomics) 

Process

Process_YChemHimage.gif

Key Benefits

  • Gain in productivity with additional resources
  • Benefit from our expertise in both chemistry and biology
  • Understand how your bioactive molecule works
  • Select the most promising molecule & develop it the optimal way

Contact our team of experts for any question or for a project discussion: 

+33 (0)1 58 10 38 29
services@hybrigenics.com

Product Discover Hybrigenics Services new offer: ULTImate YChemH for your drug discovery & development projects
Company Hybrigenics Services
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Hybrigenics Services
3-5 Impasse Reille 75014 Paris France

Tel: +33 (0)1 58 10 38 29
Fax: +33 (0)1 58 10 38 48
Email: services@hybrigenics.com



Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!